5116 Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices 

health equity issues and provide guidance on 

opportunities for CDC. 

Matters for Discussion: The Health 

Disparities Subcommittee members will 

discuss progress toward implementation of 

the Health Disparities Subcommittee 

recommendations and discussion of the 

Healthy People 2020 progress review on 

social determinants of health and LGBT 

health. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Leandris Liburd, Ph.D., M.P.H., M.A., 

Designated Federal Officer, Health 

Disparities Subcommittee, Advisory 

Committee to the Director, CDC, 1600 Clifton 

Road NE., M/S K–77, Atlanta, Georgia 30333 

Telephone (770) 488–8343, Email: LEL1@

cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2015–01766 Filed 1–29–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Occupational Safety and 

Health Education and Research Centers 

(ERC) PAR 10–217, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

6:00 p.m.–8:00 p.m., February 23, 2015 

(Closed). 

8:00 a.m.–6:00 p.m., February 24, 2015 

(Closed). 

8:00 a.m.–6:00 p.m., February 25, 2015 

(Closed). 

8:00 a.m.–6:00 p.m., February 26, 2015 

(Closed). 

Place: Renaissance Atlanta Midtown Hotel, 

866 West Peachtree Street NW., Atlanta, 

Georgia 30308, Telephone: (678) 412–2400. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Occupational Safety and Health 

Education and Research Centers (ERC) PAR 

10–217.’’ 

FOR FURTHER INFORMATION CONTACT: 

George Bockosh, M.S., Scientific Review 

Officer, National Institute for 

Occupational Safety and Health 

(NIOSH), CDC, 2400 Century Center 

Parkway NE., 4th Floor, Mailstop E–74, 

Atlanta, Georgia 30345, Telephone: 

(412) 386–6465, GGB0@CDC.GOV and 

Donald Blackman, Ph.D., Scientific 

Review Officer, NIOSH, CDC, 2400 

Century Center Parkway NE., 4th Floor, 

Room 4204, Mailstop E–74, Atlanta, 

Georgia 30345, Telephone: (404) 498– 

6185, DYB7@CDC.GOV. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–01817 Filed 1–29–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns ‘‘Comprehensive High-Impact 

HIV Prevention Projects for CommunityBased Organizations’’, Funding 

Opportunity Announcement (FOA) 

PS15–1502, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 9:00 a.m.–4:00 p.m. EST, 

Panels 1–7; February 24, 2015 (Closed), 9:00 

a.m.–4:00 p.m. EST, Panels 8–14; February 

25, 2015 (Closed), 9:00 a.m.–4:00 p.m. EST, 

Panels 15–19; February 26, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Comprehensive High-Impact 

HIV Prevention Projects for CommunityBased Organizations’’ FOA PS15–1502. 

Contact Person for More Information: Lisa 

R. Williams, Public Health Analyst, CDC, 

1600 Clifton Road NE., Mailstop E07, 

Atlanta, Georgia 30333, Telephone: (404) 

639–1877. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–01769 Filed 1–29–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices (ACIP) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following meeting of the 

aforementioned committee. 

Times and Dates: 

8:00 a.m.–5:45 p.m., February 25, 2015. 

8:00 a.m.–1:00 p.m., February 26, 2015. 

Place: CDC, Tom Harkin Global 

Communications Center, 1600 Clifton Road 

NE., Building 19, Kent ‘‘Oz’’ Nelson 

Auditorium, Atlanta, Georgia 30333. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The committee is charged with 

advising the Director, CDC, on the 

appropriate use of immunizing agents. In 

addition, under 42 U.S.C. 1396s, the 

committee is mandated to establish and 

periodically review and, as appropriate, 

revise the list of vaccines for administration 

to vaccine-eligible children through the 

Vaccines for Children (VFC) program, along 

with schedules regarding the appropriate 

periodicity, dosage, and contraindications 

applicable to the vaccines. Further, under 

provisions of the Affordable Care Act, at 

section 2713 of the Public Health Service 

Act, immunization recommendations of the 

ACIP that have been adopted by the Director 

of the Centers for Disease Control and 

Prevention must be covered by applicable 

health plans. 

Matters for discussion: The agenda will 

include discussions on: General 

recommendations; meningococcal vaccines; 

human papillomavirus vaccines; influenza; 


asabaliauskas on DSK5VPTVN1PROD with NOTICES